Business News | Glenmark Pharmaceuticals Receives Tentative ANDA Approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 Per Cent|0.064 Per Cent
Get latest articles and stories on Business at LatestLY. Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 per cent|0.064 per cent, the generic version of Enstilar®1 Foam, 0.005 per cent|0.064 per cent, of Leo Pharma AS. Business News | Glenmark Pharmaceuticals Receives Tentative ANDA Approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005 Per Cent|0.064 Per Cent.
Source: latestly.com